<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> of the lower esophagus that is usually associated with <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> (GER), was found in three children on long-term antileukemia chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Two of the children had been on a standard <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) maintenance protocol with 2 to 3 years of <z:chebi fb="0" ids="44185">methotrexate</z:chebi> and <z:chebi fb="1" ids="50667">6-mercaptopurine</z:chebi> administration </plain></SENT>
<SENT sid="2" pm="."><plain>The third child received <z:chebi fb="0" ids="41977">daunorubicin</z:chebi>, <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>, and 6-thioguanine for treatment of <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>None of the patients had clinical or pathologic evidence of GER disease </plain></SENT>
<SENT sid="4" pm="."><plain>We propose that the <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> in these patients did not result from the usual peptic <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, but rather from chemotherapy-induced esophageal mucosal injury </plain></SENT>
</text></document>